15d (edited) • Peptide Tips
SS-31 Disappearing from the Research Market? Here's the Real Story
So I've been getting questions about SS-31 and wanted to clear up what's actually happening.
The Short Version: SS-31 is getting fast-tracked for FDA approval, and now the company holding the patent is sending cease and desist letters to research vendors. But no, the compound's not actually disappearing - just getting renamed.
Why This Is Happening Now
SS-31 (Elamipretide) is moving through the FDA approval process, which is why the patent holder is cracking down on the name. When a compound gets closer to official pharmaceutical status, companies start protecting their intellectual property more aggressively. Makes sense - they've invested millions into getting FDA approval.
What's Actually Happening
The patent holder is enforcing their trademark rights. This is completely normal business stuff - they own the patent and trademark, so they can tell people to stop using the name "SS-31."
To put it simply: "The issue is the name — and not the compound itself."
The legal side: "When a compound is under an active patent, the patent holder has full legal authority to issue a cease-and-desist to any seller producing or distributing it without authorization."
How Vendors Are Handling It
Different companies are taking different approaches:
- Some are running flash sales to clear out inventory labeled as "SS-31" and won't restock under that name
- Others are just rebranding it with a research code (think how other compounds got coded names)
Max expects it'll go the same route as other peptides we've seen: "It's probably going to be codenamed and the COAs for it will also be coded to match."
What This Actually Means for You
The compound isn't going anywhere. You'll just see it listed under a different name - maybe something like a research code or alternative identifier. The COAs will match whatever new name vendors use.
This could happen with other patented compounds too (Tesamorelin was mentioned as potentially next).
My Take
This is just standard patent enforcement as the compound moves toward official pharmaceutical approval. The actual product doesn't change - just what it's called. Most vendors will keep carrying it under a new name.
42
12 comments
SS-31 Disappearing from the Research Market? Here's the Real Story
powered by
skool.com/peptide-price-9771
Premier peptide education hub. FREE courses on research peptides & GLP-1s. US supplier intel, safety protocols & expert community support. 🧬🚀
Suggested communities
Powered by